2023-505367-36-00已完成1 期
A PHASE 1 STUDY TO ASSESS THE EXCRETION BALANCE, PHARMACOKINETICS, AND METABOLISM OF [14C] DC 806 IN HEALTHY MALE PARTICIPANTS.
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 8
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Male
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Muhammad Baluom
Scientific
Dice Therapeutics Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
Mass Balance and Pharmacokinetics (PK) of [14C]-DC-806 in Healthy Male ParticipantsHealthy VolunteersNCT06045000DICE Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company8
已完成
不适用
PLASMA CONCENTRATION, EXCRETION AND MASS BALANCE OF ORALLY ADMINISTERED 14C-FYX-051 IN HEALTHY MALE SUBJECTSGout1003754610023213HyperuricemiaNL-OMON34440Fuji Yakuhin Co.,Ltd.6
已完成
1 期
Single Dose Study To Study The Absorption, Metabolism And Excretion Of PF-04991532HealthyNCT01469481Pfizer6
已完成
1 期
Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female SubjectsEpilepsyNCT03681158Sanofi5
已完成
1 期
Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male SubjectsDisorders of Sphingolipid MetabolismHealthy VolunteersNCT05238714Genzyme, a Sanofi Company6